Plethico Pharmaceuticals Ltd

Plethico Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Plethico Pharmaceuticals Ltd

₹ 7.94 -4.91%
13 Jun 2016
plethico.com BSE: 532739 NSE: PLETHICO
About

Plethico Pharmaceuticals Ltd is an India-based healthcare pharmaceutical company engaged in the manufacture and marketing of pharmaceutical and allied healthcare.

[ add key points ]
Website BSE NSE
  • Market Cap ₹ 30.8 Cr.
  • Current Price ₹ 7.94
  • High / Low ₹ /
  • Stock P/E 0.74
  • Book Value ₹ 415
  • Dividend Yield 0.00 %
  • ROCE 9.77 %
  • ROE 7.43 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Stock is trading at 0.02 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 9.07% over last 3 years.
  • Contingent liabilities of Rs.1,518 Cr.
  • Company has high debtors of 198 days.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Mar 2015
490 480 447 364 310 278 263 111 113
459 403 392 265 262 227 211 93 120
Operating Profit 32 77 54 100 48 51 52 18 -7
OPM % 7% 16% 12% 27% 16% 18% 20% 16% -6%
3 6 0 -0 0 -0 0 0 -320
Interest 15 35 23 29 57 36 52 12 22
Depreciation 4 10 7 27 16 15 15 11 16
Profit before tax 16 38 24 43 -24 -1 -15 -4 -365
Tax % 16% -18% 14% -2% -51% 34% -59% 0% -27%
13 44 21 44 -12 -2 -6 -4 -266
EPS in Rs 3.88 13.03 6.16 12.94 -3.52 -0.49 -1.85 -1.19 -77.99
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Sep 2006 Dec 2007 15m Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014 15m TTM
366 549 905 1,249 1,529 1,557 1,632 2,060 765
272 410 774 1,014 1,191 1,342 1,470 1,766 652
Operating Profit 93 140 131 235 338 215 161 294 113
OPM % 26% 25% 15% 19% 22% 14% 10% 14% 15%
10 38 16 27 -2 23 33 42 -320
Interest 6 10 23 35 40 89 67 175 122
Depreciation 5 7 16 17 26 18 18 64 58
Profit before tax 92 161 109 210 269 131 109 97 -386
Tax % 4% 2% -13% -3% 9% 22% 7% -14%
89 158 123 217 244 103 101 111 -278
EPS in Rs 25.81 46.48 36.21 63.68 71.74 30.21 29.79 32.49 -81.52
Dividend Payout % 10% 5% 7% 4% 3% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 10%
TTM: -52%
Compounded Profit Growth
10 Years: %
5 Years: -10%
3 Years: -23%
TTM: -56%
Stock Price CAGR
10 Years: -14%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 14%
3 Years: 9%
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Sep 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014
Equity Capital 34 34 34 34 34 34 34 34
Reserves 412 559 702 856 1,037 1,331 1,333 1,580
95 383 682 612 581 1,069 1,187 1,391
48 43 92 87 180 126 177 309
Total Liabilities 588 1,018 1,509 1,590 1,832 2,559 2,732 3,315
177 111 425 401 411 445 427 986
CWIP 24 2 191 213 255 401 395 0
Investments 43 409 199 199 199 199 199 199
344 496 694 776 967 1,514 1,711 2,130
Total Assets 588 1,018 1,509 1,590 1,832 2,559 2,732 3,315

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Sep 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014
-39 70 138 165 176 -272 -61 244
-39 -255 -409 -14 -101 -15 23 -490
146 266 167 -147 -85 357 -40 249
Net Cash Flow 68 81 -105 4 -10 70 -79 2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Sep 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014
Debtor Days 232 177 157 133 152 228 274 198
Inventory Days 42 17 114 84 73 76 72 60
Days Payable 25 16 66 35 62 23 24 32
Cash Conversion Cycle 249 177 205 181 163 281 322 225
Working Capital Days 234 204 212 177 171 300 337 281
ROCE % 20% 17% 17% 20% 14% 7% 10%

Shareholding Pattern

Numbers in percentages

Jun 2016
57.75%
2.70%
16.71%
22.84%
No. of Shareholders 16,430

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings